ArriVent BioPharma (AVBP) Change in Cash (2023 - 2026)
ArriVent BioPharma (AVBP) posted Change in Cash of $16.6 million for Q1 2026, up 124.67% sequentially from -$67.1 million in Q4 2025, and up 167.8% YoY from $6.2 million in Q1 2025.
ArriVent BioPharma (AVBP) Change in Cash (2023 - 2026) Analysis & Trends
ArriVent BioPharma has reported Change in Cash for 4 years, with the latest figure at $16.6 million in Q1 2026.
- Quarterly Change in Cash rose 167.8% year-over-year to $16.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.2 million (up 104.57% YoY) and the FY2025 annual result came in at -$28.8 million, up 62.21% from the prior year.
- Change in Cash climbed to $16.6 million in Q1 2026 per AVBP's latest filing, from -$67.1 million in the prior quarter.
- Over five years, Change in Cash peaked at $167.0 million in Q1 2024 and troughed at -$208.6 million in Q4 2024.
- A 4-year average of -$7.8 million and a median of -$15.8 million in 2024 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 494.57% in 2024, down 2409.66% in 2024.
- Over 4 years, Change in Cash stood at $9.0 million in 2023, then tumbled by 2409.66% to -$208.6 million in 2024, then jumped by 67.81% to -$67.1 million in 2025, then soared by 124.67% to $16.6 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $16.6 million, -$67.1 million, and -$93000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | ArriVent BioPharma | 1.43 Bn | 1.43 Bn | - | 92.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 92.58 Mn |
| Mar 31, 2026 | 16.56 Mn |
| Dec 31, 2025 | -67.13 Mn |
| Sep 30, 2025 | -93,000.00 |
| Jun 30, 2025 | 62.90 Mn |
| Mar 31, 2025 | -24.43 Mn |
| Dec 31, 2024 | -208.56 Mn |
| Sep 30, 2024 | -15.81 Mn |
| Jun 30, 2024 | -18.72 Mn |
| Mar 31, 2024 | 167.00 Mn |
| Dec 31, 2023 | 9.03 Mn |
| Sep 30, 2023 | -16.48 Mn |
| Jun 30, 2023 | -33.63 Mn |
| Mar 31, 2023 | 28.09 Mn |